From conference call -Aurora has grown from having 40 doctors selling Aurora's pain division product/devices to now 60 as of the call.
-Aurora is training another 300 doctors this year with an adoption success rate of 20% this could lead to seeing over 100 doctors by year end.
-Currently the average doctor returns $10k/month. Management hopes to increase the organic growth.
-DEXA-C is now selling in a controlled rollout. A larger push will be made in Q1.
-Silo-TFX is still awaiting FDA approval. Aurora has plans to make a big sales push once approvals are given.
-Break even is approx $1.2m/month now.
-Q1 will see sequentially higher sales with results out at the end of May.